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Abstract  The  present  study  was  designed  to  test  the  hypothesis  that  high  dose  dexmedeto-
midine would  increase  the  duration  of  antinociception  to  a  thermal  stimulus  in  a  rat  model
of sciatic  nerve  blockade  without  causing  nerve  damage.  The  rats  were  anesthetized  with
isoﬂurane.  After  electromyography  (EMG)  recordings,  right  sciatic  nerves  were  explored  and
perineural  injections  were  delivered:  Group  D  (n  =  7),  40  g  g  kg−1 dexmedetomidine  admin-
istration, Group  II  (n  =  6),  (0.2  mL)  saline  administration,  Group  III  (n  =  2),  only  surgically
exploration  of  the  right  sciatic  nevre.  Time  to  paw  withdrawal  latency  (PAW)  to  a  thermal
stimulus for  both  paws  and  an  assessment  of  motor  function  were  measured  every  30  min  after
the nerve  block  until  a  return  to  baseline.  The  compound  muscle  action  potential  (CMAP)  of
right and  left  sciatic  nerves  were  recorded  10  times  per  each  nerve  once  more  after  perineural
injections at  14  day.  After  EMG  recordings,  right  and  the  part  of  left  sciatic  nerve  were  excised
at a  length  of  at  minimum  15  mm  for  histopathological  examination.  Comparison  of  right/left
CMAP amplitude  ratios  before  and  14  days  after  the  procedure  showed  a  statistically  signiﬁ-
cant difference  (p  =  0.000).  There  were  no  differences  in  perineural  inﬂammation  between  the
Group D,  Group  S,  and  Group  E  at  14  days.
© 2016  Published  by  Elsevier  Editora  Ltda.  on  behalf  of  Sociedade  Brasileira  de  Anestesiologia.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).PALAVRAS-CHAVE Efeitos  de  dexmedetomidina  perineural  no  nervo  ciático  em  ratos
o  foi  desenvolvido  para  testar  a  hipótese  de  que  dexmedetomidina
 durac¸ão  da  antinocicepc¸ão  a  um  estímulo  térmico  em  modelo  deTestes  de  latência  de
retirada  da  pata;
Medidor  de  analgesia;
Resumo  O  presente  estud
em dose  alta  aumentaria  aNervo  ciático; rato de  bloqueio  do  nervo  ciático  sem  causar  danos  ao  nervo.  Os  ratos  foram  anestesiados  com
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isoﬂurano.  Após  os  registros  da  eletromiograﬁa  (EMG),  os  nervos  ciáticos  direitos  foram  explo-
rados e  injec¸ões  perineurais  foram  administradas:  Grupo  D  (n  =  7)  recebeu  40  g/kg−1 de
dexmedetomidina,  Grupo  II  (n  =  6)  recebeu  0,2  mL  de  soluc¸ão  salina,  Grupo  III  (n  =  2)  recebeu
apenas explorac¸ão  cirúrgica  do  nervo  ciático  direito.  O  tempo  de  latência  de  retirada  pata  (LRP)
a um  estímulo  térmico  para  ambas  as  patas  e  uma  avaliac¸ão  da  func¸ão  motora  foram  avaliados
a cada  30  minutos  após  o  bloqueio  do  nervo  até  o  retorno  à  fase  basal.  O  potencial  de  ac¸ão
muscular  composto  (PAMC)  dos  nervos  ciático  direito  e  esquerdo  foi  registrado  10  vezes  para
cada nervo,  mais  uma  vez,  após  as  injec¸ões  perineurais  no  14◦ dia.  Após  os  registros  da  EMG,
o nervo  ciático  direito  e  parte  do  esquerdo  foram  excisados  com  um  comprimento  de  no  mín-
imo 15  mm  para  exame  histopatológico.  A  comparac¸ão  das  proporc¸ões  da  amplitude  do  PAMC
direito/esquerdo  antes  e  14  dias  após  o  procedimento  mostrou  uma  diferenc¸a  estatisticamente
signiﬁcativa  (p  =  0,000).  Não  houve  diferenc¸as  em  inﬂamac¸ão  perineural  entre  os  grupos  D,  S  e
E aos  14  dias.
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  de  Sociedade  Brasileira  de  Anestesiologia.
Este e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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eripheral  nerve  blocks  are  frequently  used  in  surgical
rocedures  targeted  at  post-operative  pain  and  surgical
nesthesia.  Long-acting  local  anesthetics  may  also  provide
nalgesia  per  se  for  9--14  h.1--4 If  the  block  is  performed
n  the  morning  and  afternoon,  patients  generally  report
ost-operative  pain  at  night  hours.  The  need  for  opioid
ause’s  opioid-related  potential  side  effects  and  suppression
f  healing  sleep.5 Using  opioids  results  in  potential  airway
bstruction,  which  causes  saturation  to  decrease.6--8 Ideally,
ingle-time  peripheral  nerve  block  should  provide  analgesia
uring  the  ﬁrst  post-operative  night.
Interventions  targeted  increasing  the  duration  of  block
n  order  to  heal  post-operative  pain  with  many  additional
ocal  anesthetics  are  under  investigation.  The  efﬁcacy  of
lonidine  has  been  proven  in  many  regional  anesthetic
echniques.9 However,  long-acting  local  anesthetics  have
roduced  results  that  are  not  very  impressive.10,11 In  some
tudies,  no  beneﬁcial  effects  of  adding  clonidine  to  long-
cting  anesthetics  have  been  found.11
Dexmedetomidine  is  a  selective  alpha-adrenoceptor
gonist.  A  previously  performed  study  showed  that
exmedetomidine  extends  the  sensorial  and  motor  block
ime  when  combined  with  bupivacaine  in  rat  models  with
ciatic  nerve  block.12
Studies  indicated  that  local  anesthetics  result  in
yonecrosis;  however,  it  is  believed  that  the  damage  may
ot  be  clinically  important  since  the  muscles  are  regen-
rated  in  a  normal  way.13--16 Local  anesthetic  doses  are
enerally  reliable  in  healthy  human  beings;  however,  there
ay  really  be  neurotoxicity  present  in  patients  with  sub-
linical  neuropathy  diabetes  or  multiple  sclerosis.17--19 An
ncrease  in  inﬂammatory  mediators  was  identiﬁed  follow-
ng  the  administration  of  perineural  clonidine.20--25 A  study
eported  a  signiﬁcant  decrease  in  perineural  inﬂammation  at
4  h  with  the  addition  of  dexmedetomidine  to  bupivacaine  as
ompared  with  the  administration  of  bupivacaine  alone.  The
ame  study  found  that  the  perineural  inﬂammation  values
t  24  h  were  higher  as  compared  with  the  bupivacaine-
nly  saline  control  group.  The  perineural  inﬂammation
T
o
ealues  of  the  group  that  received  both  bupivacaine  and
exmedetomidine  and  the  group  that  received  only
exmedetomidine  were  similar  to  those  of  the  saline
roup.26
As  discussed  in  previous  studies,  it  is  believed  that
ecreased  perineural  inﬂammation  with  the  use  of
exmedetomidine  is  due  to  decreased  proinﬂammatory
roducts  of  healing  immune  cells  and  increased  anti-
nﬂammatory  cytokines  at  the  wound  site.20--25 It  is  very
mportant  to  determine  the  functional  statuses  of  nerves.
ne  of  the  functional  evaluation  methods  for  neural  healing
r  transmission  disorder  is  to  perform  electrophysiological
easurements.  Electromyography  is  a  common  procedure
n  clinical  and  fundamental  studies  in  the  context  of  in  vivo
nd  in  vitro  functional  nerve  studies.  It  has  a  widespread
se  in  the  electro-diagnostic  evaluation  of  peripheral  nerve
amage  of  the  sciatic  nerve  in  animal  models.  A  study  per-
ormed  showed  that  the  use  of  a  silicone  tube  ﬁlled  with
yaluronic  acid  following  end-to-end  repair  of  an  incised
erve  could  have  a  positive  effect  on  latency  and  CMAP,  and
onsequently  on  axonal  regeneration.27 CMAP  is  a  valuable
arameter  that  generally  shows  the  time  aspect  of  nerve
egeneration  and  reinnervation.28 A  study  demonstrated
hat  stimulation  single  ﬁber  electromyography  (SSFEMG)  was
 more  sensitive  electrophysiological  method  in  the  detec-
ion  of  neuromuscular  transmission  block  that  occurs  in  rats
ith  weak  muscles  and  acute  organophosphate  poisoning.29
hese  electromyographic  studies  showed  that  both  nerve
ealing  and  nerve  damage  could  be  shown  using  electromyo-
raphic  methods.  In  our  study,  we  determined  the  effects  of
exmedetomidine  injection  on  neural  transmission  by  using
lectromyographic  methods.
We  conducted  this  study  in  order  to  assess  the  effects  of
exmedetomidine  on  sciatic  nerves  of  rats  through  analges-
metry,  histopathology  and  electromyography.
ethodhis  study  was  conducted  at  the  Animal  Experiments  Lab-
ratory  of  Bag˘cılar  Teaching  and  Research  Hospital  upon
thics  committee  approval  obtained  during  the  19th  project
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mFigure  1  Induction  room  (Plexx  Model:  HNG6).
meeting  issue  2012/60,  number  HADYEK/2012-13  held  on
27.02.2012  by  the  Animal  Experiments  Local  Ethics  Com-
mittee  of  Bag˘cılar  Teaching  and  Research  Hospital,  Bakırköy
Secretariat  General  of  the  Association  of  Public  Hospitals,
Ministry  of  Health  of  the  Republic  of  Turkey.  This  study  was
conducted  in  accordance  with  the  guideline  for  the  use  and
care  of  laboratory  animals  and  the  guideline  for  use  and  care
of  mammals  in  behavioral  studies  conducted  in  the  context
of  neurological  sciences.  During  the  study,  15  male  rats  of
the  Sprague  Dawley  species  weighing  400--500  g  were  used.
Drug  preparation:  Precedex  IV  vials  (Abbott,  Dexmedeto-
midine  hydrochloride  100  g/mL)  were  diluted  using
physiological  saline  solution  at  a  ratio  of  50  g/mL.
Subfascial  sciatic  nerve  injection
After  the  rats  were  weighed,  they  were  anesthetized  with
isoﬂurane  2.5%  in  the  induction  room  (Plexx  Model:  HNG6)
(Fig.  1),  they  were  rested  in  right  lateral  decubitus  posi-
tion  and  isoﬂurane  2.5%  anesthesia  continued  to  be  provided
through  a  mask  (Fig.  1).  Lateral  incision  was  performed
on  the  leg  to  receive  the  injection.  The  superﬁcial  fas-
cia  was  separated  and  the  sciatic  nerve  was  exposed  at  a
point  proximal  to  the  bifurcation  (Fig.  2).  After  the  sciatic
nerve  exposure,  dexmedetomidine  40  g/kg  was  injected
in  perineural  space  in  Group  D  (n  =  7)  and  physiological
saline  solution  at  a  volume  equal  to  40  g/kg  dexmedeto-
midine  was  injected  in  Group  S  (n  =  6).  30G  PPD  injectors
were  used  for  injection.  In  Group  E  (n  =  2),  only  the  sci-
atic  nerve  was  exposed  and  it  was  closed  again.  The  time
of  injection  administration  was  recorded.  To  determine  the
site  where  nerve  sample  would  be  collected,  the  fascia  of
Figure  2  The  superﬁcial  fascia  was  separated  and  the  sciatic
nerve was  exposed  at  a  point  proximal  to  the  bifurcation.
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iceps  femoris  muscle  corresponding  to  the  injection  site
as  marked  using  non-absorbable  sutures  under  the  skin
hile  working  on  the  skin  preparation.  The  sutures  were  not
laced  around  the  nerve  and  did  not  touch  the  nerve.  After
he  injections  were  made,  the  incision  folds  were  closed.
he  isoﬂurane  anesthesia  was  interrupted  and  the  time  of
nesthesia  interruption  was  recorded;  the  rats  were  placed
n  their  cages  in  a  supine  position.  Then,  the  times  when  rats
eturned  to  prone  position  were  recorded  as  resumption  of
ighting  reﬂex  (RoRR).
aw  withdrawal  latency  (PWL)  testing
fter  the  rats  returned  to  prone  position,  a  plantar  analgesia
eter  (Series  8  model  336T,  IITC  Life  Science  Inc.,  Woodland
ills,  CA)  was  placed  in  the  plantar  analgesia  meter  chamber
n  order  to  perform  the  PWL  test  (Fig.  3).  The  source  of  light
as  used  as  a  heater  at  analgesia  meter.  After  the  source  of
ight  was  turned  on  and  the  temperature  at  the  point  to
hich  the  rat  claw  corresponded  reached  30 ◦C,  a  waiting
ime  of  5  min  was  allowed,  the  rat  claw  was  moved  to  a
oint  corresponding  there.  This  procedure  was  repeated  for
oth  the  right  and  left  paws.
The  rats  with  no  signs  of  neurobehavioral  abnormality
ere  kept  in  lit  and  dark  environments  for  periods  of  12  h
rom  the  beginning  until  the  end  of  the  experiment  (between
.00  and  18.00  h).  Before  surgery,  1  h  of  neurobehavioral
onitoring  per  day  was  performed  for  3  days.  A  thermal  PAW
est  was  conducted  and  the  averages  of  these  3  day  values
ere  taken  as  basal  values;  this  procedure  was  repeated
or  both  right  and  left  claws.  After  the  rats  were  taken  to
urgery  and  injection  was  administered,  a  PWL  measure-
ent  was  taken  once  every  30  min  consequently  and  this
rocedure  was  performed  for  both  right  and  left  claws.
ll  the  rats  were  monitored  for  210  min  in  neurobehavioral
erms.  Again  in  this  period,  a  motor  assessment  of  the  rear
xtremity  was  performed  once  every  30  min.  The  result  was
ecorded  as  motor  block  being  present  (motor  score  =  1),
ormal  claw  position  or  no  motor  blocks  (motor  block  =  0).
nce  the  rats  returned  to  their  basal  sensorial  and  motor
alues,  they  were  sent  back  to  their  cages.  Before  removing
he  nerve  of  rats  on  the  injection  site,  the  PWL  measure-
ents  of  both  claws  were  taken  5  times  each  every  morning
s  of  the  morning  after  the  injection  until  the  nerve  was
emoved.  The  daily  PWL  values  were  taken  as  the  average
f  these  measurements.
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Figure  5  Microscopic  images  of  the  perineural  inﬂammation
level 0.
F
l
m
p
Statistics
Statistical  calculations  were  made  using  the  software  pro-
gram  SPSS  11.5  for  Windows.  Comparison  of  anesthesiaigure  4  The  peak  to  peak  compound  muscle  action  potential
CMAP)  and  distal  motor  latency  of  the  right  and  left  sciatic
erves.
lectrophysiology  study
fter  the  rats  were  anesthetized  with  isoﬂurane  2.5%,  the
ails  of  rats  made  to  rest  in  supine  position  were  ﬁxed  on
he  working  platform.  The  needle  electrode  was  placed  in
he  gastrocnemius  muscle  and  the  sciatic  nerve  was  stimu-
ated  10  times  with  a  surface  electrode  in  a  supramaxillary
ay  at  a  suitable  point  proximal  to  the  hip  joint  (Fig.  1).
he  peak  to  peak  compound  muscle  action  potential  (CMAP)
nd  distal  motor  latency  of  the  right  and  left  sciatic  nerves
ere  recorded,  respectively  (Fig.  4).  For  electrophysiolog-
cal  study,  an  electromyography  system  (Biopac  systems,
nc.,  Model:  MP150)  was  used  and  the  software  program
abChart  7  was  used  for  the  assessment  of  measurements.
he  same  procedure  was  performed  after  administration  of
soﬂurane  anesthesia  before  injection  to  the  sciatic  nerve
nd  on  Day  14  after  the  injection  into  the  sciatic  nerve
efore  collecting  a  sample  from  the  sciatic  nerve  and  the
esults  were  compared.
istopathological  study
n  day  14  after  the  rats  were  anesthetized  with  isoﬂurane
or  the  ﬁrst  electrophysiology  study  and  drug  injection  into
he  sciatic  nerve,  the  rats  were  anesthetized  again  with
soﬂurane  and  electrophysiology  study  was  performed.  The
ormer  incision  site  in  the  rear  right  extremity  was  opened,
he  marking  suture  was  located  and  a  sciatic  nerve  sample
f  1.5  cm  in  length  was  collected  from  the  corresponding
ite.  The  same  procedure  was  repeated  for  the  rear  left
xtremity.  The  nerve  samples  were  ﬁxed  for  3  days  in  glyc-
raldehyde  2.5%  and  then  embedded  in  parafﬁn  blocks  and
ross-sections  of  5  m  were  prepared.  These  samples  were
tained  with  eosin  and  evaluated.  The  following  were  identi-
ed:  perineural  inﬂammation  in  the  sciatic  nerve  (Figs.  5--8)
0  =  no  inﬂammation,  1  =  slight  edema  and/or  inﬂammation
n  small  foci,  2  =  moderate  edema  and/or  inﬂammation  in  a
ocally  wide  area,  3  =  moderate  edema  and/or  inﬂammation
n  diffuse  areas,  local  nerve  damage  ﬁndings)  (0  =  no  lesions,
 =  damage  in  1--2%  of  axons  or  myelins,  2  =  damage  in  2--5%
f  axons  or  myelins,  3  =  damage  in  more  than  5%  of  axons  or
F
ligure  6  Microscopic  images  of  the  perineural  inﬂammation
evel 1.
yelins).  After  the  removal  sciatic  nerve,  euthanasia  was
erformed  on  rats  using  the  cervical  dislocation  method.igure  7  Microscopic  images  of  the  perineural  inﬂammation
evel 2.
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Figure  10  Comparison  of  RoRR  in  the  groups.
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to  the  basal  values;  however,  the  PWL  values  were  sta-
tistically  signiﬁcantly  longer  on  other  days  in  comparison
with  the  basal  values  (1  Day:  p  =  0.735;  2  Day:  p  =  0.028;Figure  8  Microscopic  images  of  the  perineural  inﬂammation
level 3.
durations  among  groups,  comparisons  of  RoRR  values,
histopathologically  performed  inﬂammation  and  local  nerve
damage  values  were  made  via  the  NPar  tests  Kruskal--Wallis
test.  In  cases  where  there  were  statistically  signiﬁcant  dif-
ferences  among  groups,  they  were  compared  individually
using  the  NPar  tests  Mann--Whitney  U  test.  The  rear  and
right  left  extremity  basal  PWL  values  and  PWL  values  at  30,
60,  90,  120,  150,  180,  210  min  and  on  days  1--14  of  each
and  every  group  were  compared  during  NPar  Tests  Wilcoxon
Signed  Ranks  test.  The  CMAP  and  Latency  values  were  com-
pared  using  the  ANOVA  test  among  all  three  groups.  The
comparison  of  electromyographic  values  before  the  drug
administration  and  on  Day  14  after  the  drug  administration
and  the  comparison  of  electromyographic  values  before  and
after  drug  administration  among  the  groups  were  performed
using  the  paired-t  test.  The  value  of  p  <  0.05  was  considered
statistically  signiﬁcant  for  all  the  data.
Results
When  the  durations  of  anesthesia  provided  while  admin-
istering  injections  to  rats  were  compared,  no  statistically
signiﬁcant  differences  were  found  (p  =  0.823)  (Fig.  9).
When  the  RoRR  values  of  rats  were  compared  as  per
the  groups,  statistically  signiﬁcant  differences  were  found
among  groups  (p  =  0.005).  When  the  groups  were  compared
individually,  it  was  seen  that  the  RoRR  values  in  Group  D
were  statistically  signiﬁcantly  different  than  the  other  two
groups  and  the  RoRR  values  were  longer  as  compared  to
the  two  other  groups  (Group  D--Group  S:  p  =  0.003,  Group
D--Group  E:  p  =  0.040)  (Fig.  10).
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Figure  9  Comparison  of  duration  of  anesthesia  in  the  groups.
F
gigure  11  Time-PWL  changes  in  the  right  rear  limb  in  the
roups (Seri  1,  Group  D;  Seri  2,  Group  S;  Seri  3,  Group  E).
n  Group  D
hen  the  rear  right  extremity  PWL  values  of  the  rats  were
ompared  with  their  basal  values,  it  was  seen  that  the  PWL
alues  were  lower  than  the  basal  value  in  30  min  after  drug
dministration  and  higher  in  210  min.  There  were  no  statis-
ically  signiﬁcant  differences  among  values  measured  in  60,
0,  120,  150  and  180  min  (p  = 0.018  --  p  =  0.237  --  p  =  0.237  --
 =  0.735  --  p  =  0.499  --  p  =  0.091  --  p  =  0.028)  (Fig.  11).
When  the  rear  left  extremity  PWL  values  of  the  rats  were
ompared  with  their  basal  values,  no  statistically  signiﬁ-
ant  differences  were  observed  in  60,  90,  120,  150,  180
nd  210  min  (p  =  0.044  --  p  =  0.138  --  p  =  0.067  --  p  =  0.54  --
 =  0.128  --  p  =  0.098  --  p  =  0.056)  (Fig.  12).
When  the  rear  right  extremity  PWL  values  of  rats  were
ompared  with  their  basal  values,  no  statistically  signiﬁcant
ifferences  were  seen  on  Days  1,  8,  9  and  14  as  compared0
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igure  12  Time-PWL  changes  in  the  left  rear  limb  in  the
roups  (Seri  1,  Group  D;  Seri  2,  Group  S;  Seri  3,  Group  E).
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Figure  13  Time-PWL  changes  in  the  right  rear  limb  in  the
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lroups  after  injection  (Seri  1,  Group  D;  Seri  2,  Group  S;  Seri  3,
roup E).
 Day:  p  =  0.018;  4  Day:  p  =  0.028;  5  Day:  p  =  0.043;  6  Day:
 =  0.018;  7  Day:  p  =  0.028;  8  Day:  p  =  0.128;  9  Day:  p  =  0.063;
0  Day:  p  =  0.028;  11  Day:  p  =  0.018;  12  Day:  p  =  0.028;  13
ay:  p  =  0.663;  14  Day:  p  =  0.128)  (Fig.  13).
When  the  rear  left  extremity  PWL  values  of  rats  were
ompared  with  their  basal  values,  it  was  seen  there  was
 statistically  signiﬁcant  difference  in  terms  of  measure-
ents  taken  on  Days  4--6,  9--12  throughout  14  days  and
hey  were  longer  than  the  basal  values  (1  Day:  p  =  0.612;
 Day:  p  =  0.018;  3  Day:  p  =  0.063;  4  Day:  p  =  0.018;  5  Day:
 =  0.018;  6  Day:  p  =  0.018;  7  Day:  p  =  0.091;  8  Day:  p  =  0.128;
 Day:  p  =  0.028;  10  Day:  p  =  0.125;  11  Day:  p  =  0.028;  12  Day:
 =  0.018;  13  Day:  p  =  0.028;  14  Day:  p  =  0.063)  (Fig.  14).
Motor  block  did  not  develop  in  any  of  the  rats  in  Group
.
n  Group  S
hen  the  rear  right  extremity  PWL  values  of  rats  were  com-
ared  with  their  basal  values,  no  statistically  signiﬁcant
ifferences  were  observed  in  30,  60,  90,  120,  150,  180  and
10  min  (Fig.  11).
When  the  rear  left  extremity  PWL  values  of  rats  were
ompared  with  their  basal  values,  no  statistically  signiﬁcant
ifferences  were  observed  in  30,  60,  90,  120,  150,  180  and
10  min  (Fig.  12).
When  the  rear  right  extremity  PWL  values  of  rats  were
ompared  with  their  basal  values,  there  were  signiﬁcant
ifferences  on  Days  4--7,  10,  11  and  14  and  they  were
onger  as  compared  to  the  basal  values  (1  Day:  p  =  0.345;
 Day:  p  =  0.116;  3  Day:  p  =  0.600;  4  Day:  p  =  0.046;  5  Day:
 =  0.046;  6  Day:  p  =  0.028;  7  Day:  p  =  0.028;  8  Day:  p  =  0.075;
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igure  14  Time-PWL  changes  in  the  left  rear  limb  in  the
roups  after  injection  (Seri  1,  Group  D;  Seri  2,  Group  S;  Seri
, Group  E).
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 Day:  p  =  0.207;  10  Day:  p  =  0.046;  11  Day:  p  =  0.028;  12  Day:
 = 0.116;  13  Day:  p  =  0.116;  14  Day:  p  =  0.028)  (Fig.  13).
When  the  rear  left  extremity  PWL  values  of  the  rats
ere  compared  with  their  basal  values,  there  were  statis-
ically  signiﬁcant  differences  on  Days  3--14  and  they  were
onger  than  basal  values  (1  Day:  p  =  0.116;  2  Day:  p  =  0.173;
 Day:  p  =  0.046;  4  Day:  p  =  0.046;  5  Day:  p  =  0.028;  6  Day:
 = 0.028;  7  Day:  p  =  0.917;  8  Day:  p  =  0.046;  9  Day:  p  =  0.028;
0  Day:  p  =  0.116;  11  Day:  p  =  0.028;  12  Day:  p  =  0.046;  13
ay:  p  =  0.028;  14  Day:  p  =  0.046)  (Fig.  14).
No  rats  in  Group  S  developed  motor  block.
n  Group  E
hen  the  rear  right  extremity  PWL  values  of  rats  were  com-
ared  with  their  basal  values,  no  statistically  signiﬁcant
ifferences  were  observed  in  30,  60,  90,  120,  150,  180  and
10  min  (Fig.  11).
When  the  rear  left  extremity  PWL  values  of  rats  were
ompared  with  their  basal  values,  no  statistically  signiﬁcant
ifferences  were  observed  in  30,  60,  90,  120,  150,  180  and
10  min  (Fig.  12).
When  the  rear  right  extremity  PWL  values  of  rats  were
ompared  with  their  basal  values,  no  statistically  signiﬁcant
ifferences  were  observed  on  Days  1--14  (Fig.  13).
When  the  rear  left  extremity  PWL  values  of  rats  were
ompared  with  their  basal  values,  no  statistically  signiﬁcant
ifferences  were  observed  on  Days  1--14  (Fig.  14).
No  rats  developed  motor  blocks  in  Group  E.
When  the  right  sciatic  nerves  of  rats  were  histopathologi-
ally  compared,  no  statistically  signiﬁcant  differences  were
een  among  groups  with  respect  to  inﬂammation  and  local
erve  damage  ﬁndings  (p  =  0.633  --  p  =  0.867).
When  the  left  sciatic  nerves  of  groups  were  histopatho-
ogically  compared,  no  statistically  signiﬁcant  differences
ere  seen  among  groups  in  terms  of  inﬂammation  and  local
erve  damage  ﬁndings  (p  =  0.751  --  p  =  0.668).
When  the  right  and  left  nerves  in  Group  D  were  compared
n  terms  of  histopathological  results,  there  were  no  statis-
ically  signiﬁcant  differences  in  terms  of  inﬂammation  and
ocal  nerve  damage  (p  =  0.891  --  p  =  0.705).
When  the  right  and  left  sciatic  nerves  in  Group  S were
ompared  in  terms  of  histopathological  results,  there  were
o  statistically  signiﬁcant  differences  in  terms  of  inﬂamma-
ion  and  local  nerve  damage  (p  =  0.194  --  p  = 0.317).
When  the  right  and  left  sciatic  nerves  in  Group  E  were
ompared  in  terms  of  histopathological  results,  there  were
o  statistically  signiﬁcant  differences  in  terms  of  inﬂamma-
ion  and  local  nerve  damage  (p  =  1.000  --  p  = 0.317).
When  the  Group  D,  Group  S  and  Group  E  were  com-
ared  in  terms  of  CMAP  and  latency  values  before  and
fter  the  injection,  there  were  statistically  signiﬁcant  dif-
erences  in  terms  of  post-injection  CMAP  values  (p  <  0.001)
Table  1).  There  were  no  statistically  signiﬁcant  differences
ith  respect  to  latency  values  (p  =  0.618)  (Tables  1  and  2).
The  post-injection  CMAP  measurements  were  statisti-
ally  signiﬁcantly  different  between  Group  D  and  Group  S
p  =  0.016)
There  were  statistically  signiﬁcant  differences  between
roup  D  and  Group  D  with  respect  to  post-injection  CMAP
easurements  (p  = 0.015).
Perineural  dexmedetomidine  effects  on  sciatic  nerve  in  rat  
Table  1  CMAP  amplitudes  and  latencies  of  right  and  left
sciatic  nerves  before  and  14  days  after  injection.
CMAP  amplitude
mV
Latency
ms
Before
injection-R
0.40--1.98  0.007--0.013
0.8251  ±  0.3862  0.010  ±  0.001
Before
injection-L
0.21--2.09  0.008--0.014
0.8729  ±  0.4716  0.011  ±  0.001
p 0.137  0.083
After
injection-R
0.00--1.39 0.006--0.031
0.3285  ±  0.2640 0.013  ±  0.006
After
injection-L
0.10--1.32  0.007--0.017
0.4294  ±  0.2786  0.012  ±  0.003
p 0.000  0.618
There was a statistically signiﬁcant difference between and after
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cally  signiﬁcant  differences  were  found  when  the  PWL  valuesinjection R CMAP amplitude and after injection L CMAP ampli-
tude, p = 0.000.
When  the  post-injection  CMAP  measurements  of  Group
S  and  Group  E  were  compared,  no  statistically  signiﬁcant
differences  were  found  between  them  (p  =  0.95).
When  the  pre-injection  and  Latency  values  were  com-
pared  among  Group  D,  Group  S  and  Group  E,  no  statistically
signiﬁcant  differences  were  found  (p  =  0.137  --  p  =  0.083)
(Tables  1  and  2).
When  the  pre-injection  and  post-injection  CMAP  values
of  Group  D  were  compared,  there  was  a  statistically  sig-
niﬁcant  difference  (p  <  0.001).  There  were  no  statistically
signiﬁcant  differences  among  the  pre-injection  and  post-
injection  CMAP  values  of  Group  S  and  Group  E  (p  =  0.126  --
p  =  0.548).
Discussion
This  study  is  a  placebo-controlled,  randomized  and  blind
study.  It  was  demonstrated  that  high-dose  dexmedetomidine
caused  sensorial  block  in  sciatic  nerves  of  rats  and  did  not
have  any  histopathologically  toxic  effects;  however,  their
effects  on  neural  transmission  were  not  electromyographic
studies.It was  found  that  dexmedetomidine  inhibited  paraven-
tricular  nucleus  parvocellular  neurons  by  means  of  Ih
suppression  hypothalamic  nucleus  neurons  which  are  con-
trolled  by  hyperpolarized-activated  ﬂows  and  in  direct
w
c
c
Table  2  CMAP  amplitude  ratios  of  right  to  left  sciatic  nerves  of  t
Total  Group  D  
Before
injection-R/L
0.37--2.26
1.0641  ±  0.3965a
After
injection-R/L
0.13--3.15  0.13--2.07  
0.8456 ±  0.5016  0.7297  ±  0
Signiﬁcant differences between Group D.
a The whole group.
b Group S.63
ontact  with  noradrenergic  neurons  are  called  Ih (H-ﬂow)
nd  rat  hypothalamic  nucleus  neurons  by  means  of  the  acti-
ation  of  G-protein  pair,  which  internally  regulates  the  K+
ow.30 In  the  in  vitro  study  of  rat  dorsal  ganglion  neurons,
t  was  found  that  the  combination  of  both  clonidine  and
exmedetomidine  with  lidocaine  produced  an  additive  type
f  block  interaction  on  tetrodotoxin-resistant  Na  ﬂow.31
A  previously  conducted  study  showed  that  increased  dose
f  dexmedetomidine  added  to  ropivacaine  resulted  in  a
onger  sensory  motor  blockage  duration  through  thermal
timulation  in  rats.26 The  time  of  intensive  sensorial  block
nd  time  to  return  to  normal  sensorial  functions  increased
n  a  dose-dependent  manner  with  gradually  increasing  doses
f  dexmedetomidine.26 Also,  another  study  demonstrated
hat  sensorial  and  motor  block  in  the  sciatic  nerve  block-
ge  of  rats  showed  a  signiﬁcant  increase  with  high-dose
exmedetomidine  added  to  bupivacaine.32 We  did  not  use
ny  local  anesthetic  drugs  in  our  study.  In  Group  D,  we
dministered  dexmedetomidine  40  g/kg−1 only  to  the  per-
neural  space  of  the  right  sciatic  nerve.  In  30  min  following
rug  administration  in  Group  D,  the  right  PWL  values  were
tatistically  signiﬁcantly  lower  than  basal  values  and  the
ight  PWL  values  were  statistically  signiﬁcantly  higher  than
asal  values  in  210  min.  The  left  PWL  values  were  statis-
ically  signiﬁcantly  low  in  30  min  in  comparison  with  basal
alues.  The  reason  why  the  right  and  left  PWL  values  in
0  min  were  lower  than  the  basal  values  was  that  the  RoRR
eﬂex  was  not  restored  in  any  of  the  rats  in  the  meantime,
ence  the  PWL  measurements  could  not  be  taken.  When
oth  right  and  left  PWL  values  in  Group  S  and  Group  E  were
ompared  with  basal  values,  no  statistically  signiﬁcant  dif-
erences  were  seen.  When  the  right  PWL  values  on  Days  1,  8,
 and  14  were  compared  with  basal  values,  no  statistically
igniﬁcant  differences  were  found.  However,  there  were  sta-
istically  signiﬁcant  differences  in  terms  of  the  comparison
f  PWL  values  on  the  other  days  and  they  were  longer  than
asal  values.  In  Group  D,  there  were  statistically  signiﬁcant
ifferences  between  left  PWL  values  and  basal  values  on
ays  4--6,  9--12  and  they  were  longer  than  basal  values.
n  Group  S,  there  were  statistically  signiﬁcant  differences
etween  the  right  PWL  values  and  basal  values  on  Days
--7,  10,  11  and  14  and  they  were  longer  than  basal  values.
here  were  statistically  signiﬁcant  differences  between  left
WL  values  and  basal  values  on  Days  3--6,  8--9,  11--14  and
hey  were  longer  than  basal  values.  In  Group  E,  no  statisti-ere  compared  with  basal  values  on  post-operative  days  in
ases  that  underwent  surgical  opening  and  closure.  A  study
onducted  showed  that  the  effect  of  dexmedetomidine  was
he  groups.
Group  S  Group  E
0.27--3.15  0.31--1.69
.3608a,b 0.9744  ±  0.6155b 0.8064  ±  0.4018
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t  a  signiﬁcant  degree  only  when  it  was  added  to  bupivacaine
nd  the  central  analgesic  effects  of  dexmedetomidine  were
herefore  rejected  as  the  reason  for  the  increased  duration
f  sensorial  block.32 Dexmedetomidine  alone  could  produce
either  sustainable  motor  block  nor  sensorial  block  at  a
igniﬁcant  degree.32 Clonidine  failed  to  produce  adequate
nalgesia  when  used  as  a  single  anesthetic  in  the  human
rachial  plexus  block.33 Similarly,  it  was  demonstrated  that
exmedetomidine  increased  the  sensorial  and  motor  block
uration  and  analgesia  duration  when  added  to  bupivacaine
or  targeting  the  supraclavicular  brachial  plexus  block.34 The
nalgesia  achieved  in  rats  by  dexmedetomidine  added  to
opivacaine  for  peripheral  nerve  block  develops  thanks  to
eripheral  effects.  In  this  study,  the  group  of  dexmedeto-
idine  alone  developed  short  and  partial  sensorial  block.35
ur  study  showed  that  dexmedetomidine  resulted  in  PWL
rolongation  not  only  in  the  right  sciatic  nerve,  where  it
as  injected  in  perineural  space,  but  also  in  the  left  sciatic
erve  on  speciﬁc  days  following  drug  administration.  The
ame  effect  was  also  observed  in  Group  S.  This  effect  was  not
bserved  in  Group  E.  For  that  reason,  it  would  not  be  accu-
ate  to  attribute  these  prolongations  to  dexmedetomidine;
owever,  these  effects  may  be  attributed  to  interventions
n  the  perineural  space.  More  studies  should  be  performed
n  that  subject.  However,  the  same  PWL  prolongations  in
roup  D  and  Group  S  also  took  place  in  left  sciatic  nerves.
s  for  the  left  sciatic  nerves,  no  surgical  interventions  were
ade  on  them.  This  is  one  of  the  subjects  that  merits  further
nvestigation.
When  high  dose  dexmedetomidine  is  added  to  bupiva-
aine  for  sciatic  nerve  block  in  rats,  it  does  enhance  the
lock.36
When  dexmedetomidine  is  intravenously  administered,
t  generates  sedation  and  analgesia  without  causing  respi-
atory  depression.37--40 It  may  change  sensory  perception
hrough  centrally  effective  analgesia  and  sedation.37--40
ontrary  to  the  result  of  a  previous  study  where  all
he  rats  received  a  bilateral  sciatic  nerve  block  with
oth  bupivacaine  alone  and  bupivacaine  enhanced  with
exmedetomidine,36 the  results  of  the  study  where  a  uni-
ateral  block  was  achieved  showed  that26 the  effects  of
exmedetomidine  were  dominant  at  the  peripheral  nerve
evel.26 Dexmedetomidine  at  a  very  high  dose  of  20  g/kg−1
as  very  large,  systemic  effects  that  further  prolong  RoRR
t  a  signiﬁcant  degree.26 In  our  study,  the  duration  of  RoRR
eﬂex  in  Group  D  was  statistically  signiﬁcantly  higher  than
he  other  groups.
Various  in  vitro  and  in  vivo  studies  have  been  conducted
n  order  to  understand  whether  dexmedetomidine  has  toxic
ffects  on  nerve  cells.  Schoeler  et  al.41 exposed  organotypic
ippocampal  slices  to  dexmedetomidine  and  create  a  focal,
echanical  trauma  in  order  to  show  that  dexmedetomidine
rovided  a  neuron-protective  effect  in  an  in  vitro  traumatic
rain  model.  Sanders  et  al.42 showed  that  dexmedetomidine
revented  cortical  apoptosis  under  in  vitro  and  in  vivo  condi-
ions.  In  another  study  that  was  conducted,  the  combination
f  bupivacaine  and  dexmedetomidine  were  compared  with
upivacaine  alone  and  it  was  associated  with  signiﬁcantly
ess  perineural  inﬂammation  at  24  h.36
A  study  observed  ﬁndings  indicating  that  dexmedetomi-
ine  5  or  10  g injected  into  the  epidural  space  in  rabbits
esulted  in  the  demyelination  of  oligodendrocytes  in  theA.  Yektas¸  et  al.
hite  matter  of  the  spinal  cord.43 However,  it  was  reported
hat  the  neurotoxic  effects  of  epidural  dexmedetomidine
ould  have  been  due  to  the  injury  of  spinal  cord  vascular
esources  due  to  the  pH  effect  or  the  direct  effects  of  epidu-
al  catheter  insertion.43 In  a  study  that  was  conducted,12 it
as  surprising  to  see  that  the  sciatic  nerves  did  not  affect
yelins  or  axons  when  dexmedetomidine  was  used  at  a
ose  of  28--40  g/kg−1; however,  it  had  caused  a  signiﬁcant
yelin  damage  when  administered  epidurally  to  rabbits  at
 dose  of  6.25  g/kg−1.43 The  perineural  inﬂammation  val-
es  were  similar  to  the  saline  control  group  in  the  group
eceiving  bupivacaine  enhanced  with  dexmedetomidine  and
n  the  group  receiving  bupivacaine  alone.12 This  situation
as  attributed  to  the  capacity  of  alpha-2  agonists  to  reduce
nﬂammatory  response.20,22,21,23,44,25,45 In  the  study  that  we
arried  out,  there  were  no  statistically  signiﬁcant  differ-
nces  in  all  three  groups  with  respect  to  histopathological
ndings  of  inﬂammation  and  local  nerve  damage  in  the
erineural  space  of  the  right  and  left  sciatic  nerve  cross-
ections.
We  have  not  encountered  any  studies  in  the  literature
here  electromyographic  values  were  compared  before  and
fter  the  injection  of  dexmedetomidine  in  the  sciatic  nerve.
he  assessment  of  latency  is  an  indication  of  the  functional
xons,  number  and  quality  of  valid  axons  and  therefore  the
unctional  status  of  motor  neurons  that  are  studied.46 There
ere  no  statistically  signiﬁcant  differences  in  any  of  the
roups  in  terms  of  pre-injection  and  post-injection  Latency
alues  in  our  study.  In  our  study,  the  post-injection  CMAP
alues  in  Group  D  were  statistically  signiﬁcantly  different
s  compared  to  the  other  groups  and  they  had  decreased
ollowing  injection.  In  Group  D,  the  pre-injection  and  post-
njection  CMAP  values  were  also  statistically  signiﬁcantly
ifferent  and  decreased  following  the  injection.  With  CMAP,
 values  are  recorded  on  the  basis  of  the  muscle  that  is  stud-
ed:  1  --  size  of  the  motor  unit  innervated  by  axons,  2  --  size
f  the  motor  nerve  ﬁbers  that  respond  to  the  stimulus  and
 --  synchronization  of  their  responses.47
In  conclusion,  the  injection  of  perineural  dexmedetomi-
ine  to  the  sciatic  nerve  in  rats  prolonged  the  PWL  value
n  210  min  and  prolonged  the  post-injection  PWL  values  on
ays  2--7,  10--13.  The  duration  of  RoRR  reﬂex  had  been  pro-
onged  at  a  statistically  signiﬁcant  level  in  rats  that  received
erineural  dexmedetomidine  injection.  Perineural  injection
f  dexmedetomidine  into  the  sciatic  nerve  did  not  result  in
 statistically  signiﬁcant  perineural  inﬂammation  increase
r  local  nerve  damage;  however,  the  CMAP  values  on  Day  14
ollowing  the  perineural  injection  of  dexmedetomidine  into
he  sciatic  nerve  were  found  to  be  statistically  signiﬁcantly
ower.
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